Posts by: Marisa Wexler, MS

Marisa Wexler, MS

Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

September 18, 2019September 18, 2019

FTC Warns Companies Against Unsubstantiated Advertising of CBD Products for ALS

News

The U.S. Federal Trade Commission (FTC) sent warning letters to three companies that sell cannabis-based products containing cannabidiol (CBD), cautioning them that making unsubstantiated claims about the health benefits ... Read more

September 9, 2019September 11, 2019

Study Supports Cdk5 as Therapeutic Target for ALS

News

Inhibition of a protein called Cdk5 in the brain increases lifespan and improves motor function in mice with amyotrophic lateral sclerosis (ALS), a new study reports. This evidence supports ... Read more

September 3, 2019September 5, 2019

Measures of Lung Health Help to Predict Likely Outcomes in ALS Patients, Study Suggests

News

Measuring lung function can help to predict overall disease progression in people with amyotrophic lateral sclerosis (ALS), a study suggests. “Classifying Amyotrophic Lateral Sclerosis Patients by Changes in Forced ... Read more

August 26, 2019September 5, 2019

New Dynamic Neck Brace May Improve Head, Neck Range of Motion for ALS Patients, Study Says

News

A newly developed robotic neck brace may improve quality of life for people with amyotrophic lateral sclerosis (ALS) and allow researchers a more detailed assessment of head and neck ... Read more

July 2, 2019July 2, 2019

Klotho Protein Protects Brains of ALS Mice, Study Suggests

News

The klotho protein may have brain-protecting effects in amyotrophic lateral sclerosis (ALS), according to a study in mice that may become a basis for developing new therapies. The study, ... Read more

June 26, 2019June 26, 2019

Copper-ATSM Prevented Motor Neuron Loss, Reduced Brain Inflammation in Mouse Model of SALS, Study Shows

News

Copper-ATSM — a compound originally used as an imaging agent — prevented motor neuron loss and reduced brain inflammation in a mouse model of sporadic amyotrophic lateral sclerosis (ALS), ... Read more

May 10, 2019August 2, 2019

#AANAM — Research Examines Clinical, Genetic Features of ALS Type 4

News

New research details some of the clinical and genetic changes and imaging features seen in patients with amyotrophic lateral sclerosis type 4 (ALS4), a subtype of juvenile amyotrophic lateral ... Read more

May 8, 2019August 2, 2019

#AANAM – Art Therapy Can Improve Psychological Well-Being In ALS Patients, Study Reports

News

Making digital art can be beneficial for the psychological health of people with amyotrophic lateral sclerosis (ALS), a proof-of-concept study showed. The findings, “BRIDGE: Dynamic Imagery and Art Therapy ... Read more

May 7, 2019August 2, 2019

#AANAM — Radicava May Limit Functional Decline in ALS Patients, Review Study Suggests

News, Radicava

Radicava (edaravone) may prevent functional deterioration in amyotrophic lateral sclerosis (ALS) patients, results from a literature review suggest. Findings from the review, “Safety and Efficacy of Edaravone in Delaying ... Read more

May 7, 2019August 2, 2019

#AANAM — Leukemia Therapy May Also Treat ALS, Mouse Study Suggests

News

A cancer therapy called imatinib mesylate (sold under the brand name Gleevec) has the potential to slow progression in amyotrophic lateral sclerosis (ALS) and extend survival, research in mice ... Read more

Pin It on Pinterest